Pulse Biosciences Inc [PLSE] stock is trading at $19.29, up 1.58%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PLSE shares have gain 8.55% over the last week, with a monthly amount glided 27.16%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulse Biosciences Inc [NASDAQ: PLSE] stock has seen the most recent analyst activity on July 07, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $22. Previously, Stephens started tracking the stock with Overweight rating on July 27, 2021, and set its price target to $28. On March 11, 2021, Maxim Group initiated with a Buy rating and assigned a price target of $40 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $40 on January 26, 2021. H.C. Wainwright upgraded its rating to a Buy and raised its price target to $16 on May 12, 2020. H.C. Wainwright downgraded its rating to Neutral for this stock on February 14, 2020, and downed its price target to $6. In a note dated February 25, 2019, H.C. Wainwright initiated an Buy rating and provided a target price of $27 on this stock.
Pulse Biosciences Inc [PLSE] stock has fluctuated between $13.77 and $25.00 over the past year. Pulse Biosciences Inc [NASDAQ: PLSE] shares were valued at $19.29 at the most recent close of the market.
Analyzing the PLSE fundamentals
Gross Profit Margin for this corporation currently stands at 0.01% with Operating Profit Margin at -43.41%, Pretax Profit Margin comes in at -40.88%, and Net Profit Margin reading is -40.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.57, Equity is -0.65 and Total Capital is -0.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.80 points at the first support level, and at 18.31 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.09, and for the 2nd resistance point, it is at 20.89.
Ratios To Look Out For
For context, Pulse Biosciences Inc’s Current Ratio is 12.05. Also, the Quick Ratio is 12.04, while the Cash Ratio stands at 11.85.
Transactions by insiders
Recent insider trading involved Danahy Kevin Patrick, Chief Commercial Officer, that happened on Sep 18 ’25 when 20000.0 shares were sold. Chief Commercial Officer, Danahy Kevin Patrick completed a deal on Sep 19 ’25 to sell 400.0 shares. Meanwhile, Chief Technology Officer UECKER DARRIN sold 25000.0 shares on Sep 16 ’25.
